Clinical Trial Update: Combination Therapy With Fecal Microbiota Transplantation and Vedolizumab for Induction of Ulcerative Colitis [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating induction of ulcerative colitis with a combination of fecal microbiota transplantation and vedolizumab has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Fecal microbiota transplantation (fecal microbiota transplantation)
• Vedolizumab (vedolizumab)

Snippet

Sponsor: McMaster University | Conditions: Ulcerative Colitis | Phase 4 | Status: COMPLETED